[Radiotherapy regulatory news in France in 2024: Issues of quality and safety of care]. / Actualités réglementaires en radiothérapie en France en 2024 : enjeux de qualité et sécurité des soins.

With numerous clinical, technological or strategic innovations, radiation therapy is constantly evolving, contributing to major quality and safety issues, in a context where new regulatory standards are required. In this article, we will describe the conditions for implementing and applying the requirements for accreditation, periodic certification and peer audit in France.

Committee of the new positions of the Société française de radiothérapie oncologique: Toward an advanced practice master in radiotherapy.

In 2022, the radiation therapist committee of the Association française du personnel paramédical d'electroradiologie médicale (AFPPE, French association of paramedical electroradiology technicians), the Société française de radiothérapie oncologique (SFRO, French society of radiation oncology) and the Syndicat national des radiothérapeutes oncologue (SNRO, national syndicate of radiation oncologists) have been committed to working on the development of advanced practice roles. The objective of this article is to report the activities that should be in the scope of radiation therapists advanced practice and describe the competences required for these activities. This work was carried out by six radiation therapists, six radiation oncologists and one medical physicist representatives of the French national societies for each professional group. First, a basic list of activities was established and then competences were identified for groups of activities. In total, the list includes five core competences, nine competences and nine groups of activities that can be divided into the four pillars of advanced practice. The nine groups of activities can be presented in seven different dimensions including patient care and support, treatment planning, treatment imaging and delivery, management and consultancy, quality and risk management, research and innovation, education and training. The French advanced practice competences framework was developed with a multidisciplinary group to move forward the project of a master degree in advanced practice in radiation therapy in France.

Indications for Radiation in Pancreatic Adenocarcinoma: A Review.

Pancreatic adenocarcinoma remains a deadly disease with 5 year overall survival of 10% among all stages. Standard of care for resectable disease remains surgical resection and adjuvant systemic therapy, but paradigms for borderline resectable and unresectable cases remain more nuanced. Radiation has been explored in the neoadjuvant, adjuvant, and definitive settings in a variety of randomized and non-randomized trials with mixed results. There is strong evidence to support the use of neoadjuvant radiation for borderline resectable pancreatic cancer. Utilization of radiation in the adjuvant setting remains unclear while the results of radiation therapy oncology group (RTOG) 0848 are pending.

Patient, public and practitioner partnership within imaging and radiotherapy: An exploration of the implementation and use of the college of radiographers guiding principles.

INTRODUCTION: In 2014 the National Health Service (NHS) in England released the Five Year Forward plan1, envisioning a shift in power from health professionals to patients and the public. In response the Society and College of Radiographers (SCoR) produced the "Patient, Public and Practitioner Partnership within Imaging and Radiotherapy: Guiding Principles" (P4) document which was implemented within four domains of radiography practice; service delivery, service development, education and research2. This project explored how these guidelines were implemented; and whether improvement to the quality and scope were needed, leading to making recommendations for updating the document. METHODS: A mixed methods design was adopted with two phases. Phase 1 - a survey exploring use of the P4 document's guiding principles. There was no maximum number of participants to ensure inclusivity. Phase 2 - one focus group and four one-to-one interviews from the four domains3. RESULTS: 626 participants completed the phase 1 survey. 18.85% (n=118) of participants were aware of the document and used it as a reference tool for practice, teaching, and research. 81.15% (n=508) of participants stated they were unaware of the document. Themes from phase 2; importance of service user involvement in service delivery and evaluation, resources to ensure service user involvement, suggestions to update the P4 document and use of the P4 document in radiographer education. Participants acknowledged guidance in the document was best practice. They reported more awareness of patients' needs and the effect this has on radiographers in supporting their needs. CONCLUSION: Participants recommended the document be given greater visibility. The voices of patients and the public must be heard within radiography practice. IMPLICATIONS FOR PRACTICE: Feedback from this study can be used for the future development of the P4 document.

Assessment of safety culture in radiotherapy facilities using safety performance indicators.

This paper describes the development of the Safety Performance Indicators (SPIs), the methodology for assessment of the safety culture of radiotherapy institutions using SPIs and common strengths and common areas for improvement. SPIs were categorized into eight sections which all together contain 23 attributes and each attribute has scoring criteria from 0 to 2 (in steps of 0.5). The maximum absolute cumulative score of SPIs was 46. A relative cumulative SPIs score of >80% indicates an institution strong commitment towards safety while score <50% indicates need for additional guidance to enhance safety culture. The assessment using SPIs was conducted for 17 radiotherapy institutions. The methodology of assessment includes interactive discussion, direct observations and document analysis. The relative cumulative SPIs score of seven institutions was found to be >80% while it was found in the range of 67.0% to 80% for the remaining ten institutions. Institutions were communicated about the cumulative SPIs score, areas of strengths, and areas for improvement. SPIs were found to be a good tool for safety culture assessment and can be utilized by the radiotherapy institutes for self-assessment to identify the areas of improvement. Based on SPIs score, regulatory body can grade the institutions from a radiation safety compliance point of view.

Improving accessibility to radiotherapy services in Cali, Colombia: cross-sectional equity analyses using open data and big data travel times from 2020.

In this study, we evaluated and forecasted the cumulative opportunities for residents to access radiotherapy services in Cali, Colombia, while accounting for traffic congestion, using a new people-centred methodology with an equity focus. Furthermore, we identified 1-2 optimal locations where new services would maximise accessibility. We utilised open data and publicly available big data. Cali is one of South America's cities most impacted by traffic congestion. METHODOLOGY: Using a people-centred approach, we tested a web-based digital platform developed through an iterative participatory design. The platform integrates open data, including the location of radiotherapy services, the disaggregated sociodemographic microdata for the population and places of residence, and big data for travel times from Google Distance Matrix API. We used genetic algorithms to identify optimal locations for new services. We predicted accessibility cumulative opportunities (ACO) for traffic ranging from peak congestion to free-flow conditions with hourly assessments for 6-12 July 2020 and 23-29 November 2020. The interactive digital platform is openly available. PRIMARY AND SECONDARY OUTCOMES: We present descriptive statistics and population distribution heatmaps based on 20-min accessibility cumulative opportunities (ACO) isochrones for car journeys. There is no set national or international standard for these travel time thresholds. Most key informants found the 20-min threshold reasonable. These isochrones connect the population-weighted centroid of the traffic analysis zone at the place of residence to the corresponding zone of the radiotherapy service with the shortest travel time under varying traffic conditions ranging from free-flow to peak-traffic congestion levels. Additionally, we conducted a time-series bivariate analysis to assess geographical accessibility based on economic stratum. We identify 1-2 optimal locations where new services would maximize the 20-min ACO during peak-traffic congestion. RESULTS: Traffic congestion significantly diminished accessibility to radiotherapy services, particularly affecting vulnerable populations. For instance, urban 20-min ACO by car dropped from 91% of Cali's urban population within a 20-min journey to the service during free-flow traffic to 31% during peak traffic for the week of 6-12 July 2020. Percentages represent the population within a 20-min journey by car from their residence to a radiotherapy service. Specific ethnic groups, individuals with lower educational attainment, and residents on the outskirts of Cali experienced disproportionate effects, with accessibility decreasing to 11% during peak traffic compared to 81% during free-flow traffic for low-income households. We predict that strategically adding sufficient services in 1-2 locations in eastern Cali would notably enhance accessibility and reduce inequities. The recommended locations for new services remained consistent in both of our measurements.These findings underscore the significance of prioritising equity and comprehensive care in healthcare accessibility. They also offer a practical approach to optimising service locations to mitigate disparities. Expanding this approach to encompass other transportation modes, services, and cities, or updating measurements, is feasible and affordable. The new approach and data are particularly relevant for planning authorities and urban development actors.

ESPAñOL: En este estudio, evaluamos y pronosticamos las oportunidades acumulativas para que los residentes accedan a los servicios de radioterapia en Cali, Colombia, teniendo en cuenta la congestión del tráfico, utilizando una nueva metodología centrada en las personas con un enfoque de equidad. Además, identificamos 1-2 ubicaciones óptimas donde los nuevos servicios maximizarían la accesibilidad. Utilizamos datos abiertos y macrodatos disponibles públicamente. Cali está entre las ciudades Sudamericanas más afectadas por la congestión del tráfico.Metodología: Usando un enfoque centrado en las personas, probamos una plataforma digital basada en la web desarrollada a través de un diseño participativo iterativo. La plataforma integra datos abiertos, incluyendo la ubicación de los servicios de radioterapia, los microdatos sociodemográficos desagregados de la población y los lugares de residencia, y los macrodatos de tiempos de viaje de la API de Google Distance Matrix. Usamos algoritmos genéticos para identificar ubicaciones óptimas para nuevos servicios. Pronosticamos oportunidades acumulativas de accesibilidad (ACO, por sus siglas en inglés) para el tráfico que va desde la congestión máxima hasta condiciones de flujo libre, con evaluaciones horarias hechas del 6 al 12 de julio de 2020 y del 23 al 29 de noviembre de 2020. La plataforma digital interactiva está públicamente disponible.Resultados Primarios y Secundarios: Presentamos estadísticas descriptivas y mapas de calor de la distribución de la población basados en isócronas de ACO de 20 minutos para viajes en coche. No existe un estándar nacional o internacional establecido para estos umbrales de tiempo de viaje. La mayoría de los informantes clave encontraron razonable el umbral de 20 minutos. Estas isócronas conectan el centroide poblacional ponderado de la zona de análisis de tráfico del lugar de residencia con la zona correspondiente del servicio de radioterapia con menor tiempo de viaje bajo condiciones variables de tráfico, que van desde el flujo libre hasta niveles de congestión de tráfico máximo. Además, realizamos un análisis bivariado de series temporales para evaluar la accesibilidad geográfica basada en el estrato económico. Identificamos 1-2 ubicaciones óptimas donde los nuevos servicios maximizarían el ACO de 20 minutos durante la congestión máxima del tráfico.Resultados: La congestión del tráfico redujo significativamente la accesibilidad a los servicios de radioterapia, afectando particularmente a las poblaciones vulnerables. Por ejemplo, el ACO urbano de 20 minutos en coche se redujo del 91% de la población urbana de Cali para viajes de hasta 20 minutos al servicio con flujo libre de tráfico, al 31% cuando hay congestión pico de tráfico durante la semana del 6 al 12 de julio de 2020. Los porcentajes representan la población con viajes de hasta 20 minutos en coche desde la residencia hasta el servicio de radioterapia. Grupos étnicos específicos, individuos con menor nivel educativo y residentes en las afueras de Cali experimentaron efectos desproporcionados, con la accesibilidad disminuyendo al 11% durante el tráfico máximo en comparación con el 81% durante el tráfico de flujo libre para hogares de bajos ingresos. Predecimos que agregar estratégicamente suficientes servicios en 1-2 ubicaciones en el este de Cali mejoraría notablemente la accesibilidad y reduciría las inequidades. Las ubicaciones recomendadas para los nuevos servicios se mantuvieron consistentes en nuestras dos mediciones.Estos hallazgos subrayan la importancia de priorizar la equidad y la atención integral en la accesibilidad a la atención médica. También ofrecen un enfoque práctico para optimizar las ubicaciones de los servicios para mitigar las disparidades. Es factible y accesible expandir este enfoque para abarcar otros modos de transporte, servicios y ciudades, o actualizar las mediciones. El nuevo enfoque y los datos son particularmente relevantes para las autoridades de planificación y los actores del desarrollo urbano.

PORTUGUêS: Neste estudo, avaliamos e previmos as oportunidades cumulativas para os residentes acessarem serviços de radioterapia em Cali, Colômbia, levando em consideração o congestionamento do tráfego, utilizando uma nova metodologia centrada nas pessoas com um foco na equidade. Além disso, identificamos 1-2 locais ideais onde os novos serviços poderiam maximizar a acessibilidade. Utilizamos dados abertos e big data disponíveis publicamente. Cali está entre as cidades sulamericanas mais afetadas pela congestionamento do tráfego.Metodologia: Usando uma abordagem centrada em pessoas, testamos uma plataforma digital baseada na web que foi desenvolvida através de um design participativo iterativo. A plataforma integra dados abertos, incluindo a localização dos serviços de radioterapia, microdados sociodemográficos desagregados por população e locais de residência, e big data da API Google Distance Matrix para os tempos de viagem. Utilizamos algoritmos genéticos para identificar locais ideais para novos serviços. Previmos oportunidades cumulativas de acessibilidade (ACO, por suas siglas em inglês) para o tráfego que varia desde o congestionamento máximo até condições de fluxo livre, com avaliações horárias de 6 a 12 de julho de 2020 e de 23 a 29 de novembro de 2020. A plataforma digital interativa está disponível publicamente.Resultados Primários e Secundários: Apresentamos estatísticas descritivas e mapas de calor da distribuição populacional baseados em isócronas de ACO de 20 minutos para viagens de carro. Não existe um padrão nacional ou internacional estabelecido para esses limites de tempo de viagem. A maioria dos entrevistados-chave considerou razoável o limite de 20 minutos. Essas isócronas conectam o centroide ponderado pela população da zona de análise de tráfego no local de residência e sua zona correspondente do serviço de radioterapia com o menor tempo de viagem sob condições variáveis de tráfego (que vão desde fluxo livre até níveis máximos de congestionamento do tráfego). Além disso, realizamos uma análise bivariada de séries temporais para avaliar a acessibilidade geográfica baseada na estratificação econômica. Identificamos 1-2 locais ideais onde os novos serviços maximizariam a ACO de 20 minutos durante o pico de congestionamento do tráfego.Resultados: O congestionamento do tráfego reduziu significativamente a acessibilidade aos serviços de radioterapia, afetando particularmente as populações vulneráveis. Por exemplo, a ACO urbana de 20 minutos de carro foi reduzida de 91% durante um fluxo livre de tráfego, para 31% durante picos de congestionamento de tráfego entre a semana de 6 a 12 de julho de 2020. As porcentagens representam a população com viagens de até 20 minutos de carro de sua residência até o serviço de radioterapia. Grupos étnicos específicos, indivíduos com menor nível educacional e residentes nos arredores de Cali experimentaram resultados desproporcionais, com a acessibilidade diminuindo para 11% durante o tráfego com congestionamento máximo em comparação com 81% durante o fluxo livre de tráfego para domicílios de baixa renda. Prevemos que adicionar estrategicamente serviços suficientes em 1-2 locais no leste de Cali melhoraria significativamente a acessibilidade e reduziria as desigualdades. Os locais recomendados para os novos serviços permaneceram consistentes em ambas medições. Esses resultados ressaltam a importância de priorizar a equidade e o atendimento integral na acessibilidade aos cuidados de saúde. Eles também oferecem uma abordagem prática para otimizar os locais dos serviços a fim de minimizar as desigualdades. A expansão dessa abordagem para abranger outros modos de transporte, serviços e cidades, ou a atualização das medições, é viável e acessível. A nova abordagem e os dados são particularmente relevantes para as autoridades de planejamento e os agentes do desenvolvimento urbano.

FRANçAIS: Dans cette étude, nous avons évalué et prévu les opportunités cumulées pour les résidents d'accéder aux services de radiothérapie à Cali, en Colombie, tout en tenant compte de la congestion du trafic en utilisant une nouvelle méthodologie centrée sur les personnes avec axée sur l'équité. De plus, nous avons identifié 1 à 2 emplacements optimaux où de nouveaux services maximiseraient l'accessibilité. Nous avons utilisé des données ouvertes et des macrodonnées tenues à disposition du public. Cali est l'une des villes d'Amérique du Sud les plus touchées par la congestion du trafic.Méthodologie: En utilisant une approche centrée sur les personnes, nous avons testé une plateforme numérique basée sur le web développée à travers une conception participative itérative. La plateforme intègre des données ouvertes, y compris la localisation des services de radiothérapie, les microdonnées sociodémographiques désagrégées de la population et les lieux de résidence, ainsi que les mégadonnées des temps de trajet de l'API Google Distance Matrix. Nous avons utilisé des algorithmes génétiques pour identifier les emplacements optimaux pour de nouveaux services. Nous avons prévu les opportunités cumulatives d'accessibilité (ACO, désignant l'acronyme en anglais) pour le trafic allant de la congestion maximale aux conditions de flux libre, avec des évaluations horaires du 6 au 12 juillet 2020 et du 23 au 29 novembre 2020. La plateforme numérique interactive est disponible publiquement.Résultats Primaires et Secondaires: Nous présentons des statistiques descriptives et des cartes thermiques de la distribution de la population basées sur des ACO de 20 minutes pour les trajets en voiture. Il n'existe pas de norme nationale ou internationale établie pour ces seuils de temps de trajet. La majorité des informateurs clés ont trouvé le seuil de 20 minutes raisonnable. Ces isochrones relient le centroïde pondéré par la population de la zone d'analyse du trafic au lieu de résidence à la zone correspondante du service de radiothérapie avec le temps de trajet le plus court sous des conditions de trafic variables allant du flux libre aux niveaux de congestion de trafic maximum. De plus, nous avons réalisé une analyse bivariée des séries chronologiques pour évaluer l'accessibilité géographique en fonction de la stratification économique. Nous avons identifié 1 à 2 emplacements optimaux où de nouveaux services maximiseraient l'ACO de 20 minutes pendant la congestion maximale du trafic.Résultats: La congestion du trafic a considérablement réduit l'accessibilité aux services de radiothérapie, affectant particulièrement les populations vulnérables. Par exemple, l'ACO urbain de 20 minutes en voiture est passé de 91 % de la population urbaine de Cali pour des trajets de jusqu'à 20 minutes vers le service avec un flux de trafic libre à 31 % lors des pics de congestion de trafic pendant la semaine du 6 au 12 juillet 2020. Les pourcentages représentent la population avec des trajets de jusqu'à 20 minutes en voiture depuis la résidence jusqu'au service de radiothérapie. Des groupes ethniques spécifiques, des individus ayant un niveau d'éducation inférieur et des résidents des périphéries de Cali ont subi des effets disproportionnés, avec une accessibilité diminuant à 11 % pendant le trafic maximal par rapport à 81 % pendant le flux de trafic libre pour les ménages à faible revenu. Ajouter suffisamment de services à 1-2 emplacements stratégiques dans l'est de Cali a le potential d'améliorer considérablement l'accessibilité et réduirait les inégalités. Les emplacements recommandés pour les nouveaux services sont restés cohérents dans nos deux mesures. Ces conclusions soulignent l'importance de prioriser l'équité et une prise en charge globale dans le cadre de l'accessibilité aux soins de santé. Elles offrent également une approche pratique pour optimiser les emplacements des services afin de réduire les disparités. Il est faisable et abordable d'étendre cette approche pour inclure d'autres modes de transport, services et villes, ou pour mettre à jour les mesures. La nouvelle approche et les données sont particulièrement pertinentes pour les autorités de planification et les acteurs du développement urbain.

2024 Guidelines for reporting radiation therapy in veterinary medicine.

Evidence-based medicine drives patient care decision-making; thus, accurate and complete reporting in scientific publications is paramount. A checklist for complete reporting of veterinary radiation therapy was proposed in 2012 using the recommendations of the International Commission of Radiation Units and Measurements (ICRU). The purpose of this study is to review the 2012 checklist and propose updates based on changes in technology. Significant technology advancements have gained traction in veterinary medicine, including intensity-modulated radiation therapy (IMRT) and stereotactic radiation therapy (SRT), both of which have related modality-specific ICRU reporting recommendations. The 2012 checklist and proposed 2024 checklist are then used to assess the completeness of reporting in veterinary radiation oncology publications between 2015 and 2022, of which one hundred and eight publications met the inclusion criteria. Prior to the publication of the 2012 checklist (2005-2010), only nine checklist items showed a good level of completeness in reporting, and from 2015 to 2022, this increased to 16 items. Encouraging and/or requiring the use of reporting checklists at the time of manuscript submission may be responsible for this improvement in reporting. Using the 2024 checklist, which is more relevant to publications discussing IMRT and SRT treatments, only 14 of the analyzed checklist items (34%) show a good level of completeness in reporting, suggesting there is a need for updated guidelines to capture the nuances of advanced techniques. This study proposes a 2024 checklist that can be used as a guideline for future reporting of radiation therapy in veterinary medicine.

A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy.

BACKGROUND AND PURPOSE: Artificial Intelligence (AI) models in radiation therapy are being developed with increasing pace. Despite this, the radiation therapy community has not widely adopted these models in clinical practice. A cohesive guideline on how to develop, report and clinically validate AI algorithms might help bridge this gap. METHODS AND MATERIALS: A Delphi process with all co-authors was followed to determine which topics should be addressed in this comprehensive guideline. Separate sections of the guideline, including Statements, were written by subgroups of the authors and discussed with the whole group at several meetings. Statements were formulated and scored as highly recommended or recommended. RESULTS: The following topics were found most relevant: Decision making, image analysis, volume segmentation, treatment planning, patient specific quality assurance of treatment delivery, adaptive treatment, outcome prediction, training, validation and testing of AI model parameters, model availability for others to verify, model quality assurance/updates and upgrades, ethics. Key references were given together with an outlook on current hurdles and possibilities to overcome these. 19 Statements were formulated. CONCLUSION: A cohesive guideline has been written which addresses main topics regarding AI in radiation therapy. It will help to guide development, as well as transparent and consistent reporting and validation of new AI tools and facilitate adoption.

Reporting Standards for Complication Studies of Radiation Therapy for Pediatric Cancer: Lessons From PENTEC.

The major aim of Pediatric Normal Tissue Effects in the Clinic (PENTEC) was to synthesize quantitative published dose/-volume/toxicity data in pediatric radiation therapy. Such systematic reviews are often challenging because of the lack of standardization and difficulty of reporting outcomes, clinical factors, and treatment details in journal articles. This has clinical consequences: optimization of treatment plans must balance between the risks of toxicity and local failure; counseling patients and their parents requires knowledge of the excess risks encountered after a specific treatment. Studies addressing outcomes after pediatric radiation therapy are particularly challenging because: (a) survivors may live for decades after treatment, and the latency time to toxicity can be very long; (b) children's maturation can be affected by radiation, depending on the developmental status of the organs involved at time of treatment; and (c) treatment regimens frequently involve chemotherapies, possibly modifying and adding to the toxicity of radiation. Here we discuss: basic reporting strategies to account for the actuarial nature of the complications; the reporting of modeling of abnormal development; and the need for standardized, comprehensively reported data sets and multivariate models (ie, accounting for the simultaneous effects of radiation dose, age, developmental status at time of treatment, and chemotherapy dose). We encourage the use of tools that facilitate comprehensive reporting, for example, electronic supplements for journal articles. Finally, we stress the need for clinicians to be able to trust artificial intelligence models of outcome of radiation therapy, which requires transparency, rigor, reproducibility, and comprehensive reporting. Adopting the reporting methods discussed here and in the individual PENTEC articles will increase the clinical and scientific usefulness of individual reports and associated pooled analyses.

[The quality and safety approach in radiotherapy : an added value for the patient]. / La démarche qualité et sécurité en radiothérapie : une plus-value pour le patient.

Radiation therapy is the use of radiation to treat cancer cells while preserving healthy tissue. More than half of cancer patients will receive radiation therapy at some point during their treatment. The implementation of a Quality Management System (QMS) in radiotherapy departments guarantees high quality care and optimal safety for patients. The QMS is a set of policies, procedures and processes aimed at ensuring effective management of the quality of treatments. It is crucial for planning, implementing, monitoring and continuously improving the care of radiotherapy patients. The benefits of the QMS for patients are multiple. It provides high quality support through specific protocols and deadlines. The security of processing is reinforced by the continuous training of personnel, the monitoring of incidents and the analysis of errors. Developing a culture of safety and continuous improvement also helps to minimize risk. In conclusion, the implementation of a QMS in radiotherapy departments guarantees quality care, secure and adapted to the individual needs of patients. This improves patient satisfaction while reducing the risk of errors.

La radiothérapie consiste à utiliser des radiations pour traiter les cellules cancéreuses, tout en préservant les tissus sains. Plus de la moitié des patients atteints de cancer recevront une radiothérapie à un moment donné de leur traitement. La mise en place d'un Système de Management Qualité (SMQ) dans les services de radiothérapie garantit des soins de haute qualité et une sécurité optimale pour les patients. Le SMQ est un ensemble de politiques, procédures et processus visant à assurer la gestion efficace de la qualité des traitements. Il est crucial pour planifier, implémenter, contrôler et améliorer continuellement la prise en charge des patients en radiothérapie. Les avantages du SMQ sont multiples. Il assure une prise en charge de haute qualité grâce à des protocoles et des délais spécifiques. La sécurité des traitements est renforcée par la formation continue du personnel, la surveillance des incidents et l'analyse des erreurs. Le développement d'une culture de sécurité et d'amélioration continue contribue également à minimiser les risques. En conclusion, la mise en place d'un SMQ dans les services de radiothérapie garantit des traitements de qualité, sécurisés et adaptés aux besoins individuels des patients. Cette approche améliore la satisfaction des patients, tout en réduisant les risques d'erreurs.

Application of LiMgPO4 crystal for proton beam quality control in radiotherapy.

The radioluminescence (RL) emitted by LiMgPO4 detector under proton beam irradiation was investigated in real time at the radiotherapy facility in the Institute of Nuclear Physics Polish Academy of Sciences in Krakow. The facility uses protons accelerated by the AIC-144 isochronous cyclotron up to the energy of 60 MeV. The measurements of RL were carried out using a remote optical fiber device with a luminophore detector and photomultiplier located at opposite ends of the optical fiber. A thin slice of LiMgPO4 doped with Tm (1.2 mol%) crystal was exposed to the proton beam. The tested detector allowed for the measurement of proton beam current, flux fluence and determination of proton beam time structure parameters. The investigation of LiMgPO4 crystal showed its high sensitivity, fast reaction time to irradiation and possibility of application as the detector for control of proton beam parameters.

Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor.

Computed tomography (CT), MR imaging, and PET with fluorodeoxyglucose F18/CT are commonly used for radiation therapy planning; however, issues including precise nodal staging on CT or false positive results on PET/CT limit their usability. Clinical trials using fibroblast activation protein ligands for additional imaging have provided promising results regarding staging and target volume delineation-particularly suitable for sarcoma, some gastrointestinal tumors, head and neck tumors, and lung and pancreatic cancer. Although further prospective trials are necessary to identify clinical settings for its application in radiation oncology, fibroblast activation protein inhibitor PET/CT indisputably represents an excellent opportunity for assisting radiotherapy planning.

Radiotherapy Deserts: The Impact of Race, Poverty, and the Rural-Urban Continuum on Density of Providers and the Use of Radiation Therapy in the US.

PURPOSE: Prior efforts to characterize disparities in radiation therapy access and receipt have not comprehensively investigated interplay between race, socioeconomic status, and geography relative to oncologic outcomes. This study sought to define these complex relationships at the US county level for prostate cancer (PC) and invasive breast (BC) cancer to build a tool that facilitates identification of "radiotherapy deserts"-regions with mismatch between radiation therapy resources and oncologic need. METHODS AND MATERIALS: An ecologic study model was constructed using national databases to evaluate 3,141 US counties. Radiation therapy resources and use densities were operationalized as physicians to persons at risk (PPR) and use to persons at risk (UPR): the number of attending radiation oncologists and Medicare beneficiaries per 100,000 persons at risk, respectively. Oncologic need was defined by "hot zone" counties with ≥2 standard deviations (SDs) above mean incidence and death rates. Univariable and multivariable logistic regressions examined links between PPR and UPR densities, epidemiologic variables, and hot zones for oncologic outcomes. Statistics are reported at a significance level of P < .05. RESULTS: The mean (SD) PPR and UPR densities were 2.1 (5.9) and 192.6 (557.6) for PC and 1.9 (5.3) and 174.4 (501.0) for BC, respectively. Counties with high PPR and UPR densities were predominately metropolitan (odds ratio [OR], 2.9-4.4), generally with a higher percentage of Black non-Hispanic constituents (OR, 1.5-2.3). Incidence and death rate hot zones were largely nonmetropolitan (OR, 0.3-0.6), generally with a higher percentage of Black non-Hispanic constituents (OR, 3.2-6.3). Lower PPR density was associated with death rate hot zones for both types of cancer (OR, 0.8-0.9); UPR density was generally not linked to oncologic outcomes on multivariable analysis. CONCLUSIONS: The study found that mismatch between oncologic need with PPR and UPR disproportionately affects nonmetropolitan communities with a higher percentage of Black non-Hispanic constituents. An interactive web platform (bit.ly/densitymaps) was developed to visualize "radiotherapy deserts" and drive targeted investigation of underlying barriers to care in areas of highest need, with the goal of reducing health inequities in this context.

Gynecologic radiation therapy in low and middle income countries during the COVID-19 pandemic.

The COVID-19 pandemic has forever affected healthcare and posed an incredible challenge to our society to care for our sick. Patients with cancer were found early on to have higher rates of complications with COVID-19. Radiation therapy is an integral part of treatment for many types of gynecologic cancer and adaptation on its utilization during the pandemic varied across the globe. In this review, we detail certain guidelines for the use of radiation in gynecologic cancers during the pandemic as well as real world accounts of how different countries adapted to these guidelines or created their own based on individualized resources, staffing, government restrictions, and societal norms. Critically, this review demonstrates the breadth of fractionation schemes and technologies used when resources were limited but highlights the importance of long term follow-up for many of our patients during this time.

Evaluation of the histopathologic status of rectal adenocarcinoma and its regional lymph nodes after neoadjuvant therapy, and its relation to the duration of disease-free survival.

INTRODUCTION: Colorectal cancer is one of the most common malignant tumors and has a relatively poor prognosis. Lymph node involvement is considered the most important prognostic factor. MATERIALS AND METHODS: During a retrospective cohort study, 132 patients with locally advanced rectal cancer who underwent neoadjuvant chemoradiotherapy followed by surgery for resectable rectal cancer from 2010 to 2015 in Sina hospital were reviewed. RESULTS: Multivariable analysis was performed and shown the clinical stage was not a representative factor for disease-free survival (P = 0.187), but Dworak Tumor Regression Grading were significantly associated with higher disease-free survival (P = 0.000) in stage II and stage III. The total number of retrieved lymph nodes and involved lymph nodes in the same clinical stage were statistically associated with higher mean disease-free survival in patients (P = 0.000 in both conditions). CONCLUSION: In the same clinical stage, increasing the Dworak Tumor Regression Grading reduced the risk of rectal cancer recurrence. Increasing total number of retrieved lymph nodes and involved lymph nodes, 2.14 times and 3.87 times increased the risk of recurrence, respectively.

Guidelines for external radiotherapy and brachytherapy procedures: 3rd edition.

The purpose of the first two editions of the guidelines for external radiotherapy procedures, published in 2007 and 2016 respectively, was to issue recommendations aimed at optimising, harmonising and standardising practices. The purpose of this third edition, which includes brachytherapy, is identical while also taking into account recent technological improvements (intensity modulation radiation therapy, stereotactic radiotherapy, and three-dimension brachytherapy) along with findings from literature. Part one describes the daily use of general principles (quality, security, image-guided radiation therapy); part two describes each treatment step for the main types of cancer.

Specificities of clinical research in radiotherapy.

The aim of this review is to present the specificities of clinical research in radiation oncology. Objectives are similar to all research in oncology: to improve the efficacy and to decrease toxic effects. Phase III trials remain the main methodology to demonstrate an improvement in efficiency, but phase I-II and registers are also important tools to validate an improvement in the therapeutic index with new technologies. In this article we discuss the special features of end-points, selection of population, and design for radiation oncology clinical trials. Quality control of delivered treatments is an important component of these protocols. Financial issues are also discussed, in the particular context of France.

Guide for paediatric radiotherapy procedures.

A third of children with cancer receive radiotherapy as part of their initial treatment, which represents 800 paediatric irradiations per year in France carried out in 15 specialized centres approved on the recommendations of the French national cancer institute in decreasing order of frequency, the types of cancer that require irradiation are: brain tumours, neuroblastomas, Ewing's sarcomas, Hodgkin's lymphomas, soft tissue sarcomas including rhabdomyosarcomas, and nephroblastomas. The treatment guidelines follow the recommendations of the French society for childhood cancers (SFCE) or the French and European prospective protocols. The therapeutic indications, the technical and/and ballistic choices of complex cases are frequently discussed during bimonthly paediatric radiotherapy technical web-conferences. All cancers combined, overall survival being 80%, long-term toxicity logically becomes an important concern, making the preparation of treatments complex. The irradiation methods include all the techniques currently available: 3D conformational irradiation, intensity modulation radiation therapy, irradiation under normal or hypofractionated stereotaxic conditions, brachytherapy and proton therapy. We present the update of the recommendations of the French society for radiation oncology on the indications, the technical methods of realization and the organisation and the specificities of paediatric radiation oncology.